3-120682101-A-G
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PM2PP3_StrongPP5_Moderate
The ENST00000283871.10(HGD):āc.11T>Cā(p.Leu4Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000274 in 1,461,734 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (ā ).
Frequency
Consequence
ENST00000283871.10 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HGD | NM_000187.4 | c.11T>C | p.Leu4Ser | missense_variant | 1/14 | ENST00000283871.10 | NP_000178.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HGD | ENST00000283871.10 | c.11T>C | p.Leu4Ser | missense_variant | 1/14 | 1 | NM_000187.4 | ENSP00000283871 | P1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1461734Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 727190
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Alkaptonuria Pathogenic:3
Likely pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Oct 08, 2024 | Variant summary: HGD c.11T>C (p.Leu4Ser) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 251296 control chromosomes. c.11T>C has been reported in the literature in individuals affected with Alkaptonuria as a compound heterozygous genotype or without reported genotype (e.g. Ascher_2019, Phornphutkul_2002, Vilboux_2009). These data indicate that the variant may be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 30737480, 12501223, 19862842). ClinVar contains an entry for this variant (Variation ID: 1456230). Based on the evidence outlined above, the variant was classified as likely pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 31, 2021 | For these reasons, this variant has been classified as Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt HGD protein function. This variant has been observed in individual(s) with alkaptonuria (PMID: 19862842, 12501223, 16085442, Invitae). This variant is not present in population databases (ExAC no frequency). This sequence change replaces leucine with serine at codon 4 of the HGD protein (p.Leu4Ser). The leucine residue is moderately conserved and there is a large physicochemical difference between leucine and serine. - |
Pathogenic, no assertion criteria provided | research | Department Of Human Genetics, Institute Of Clinical And Translational Research, Biomedical Research Center, Slovak Academy Of Sciences | - | The variant was originally described in AKU patient in PMID:12501223. It has been submitted to the HGD gene mutation database (http://hgddatabase.cvtisr.sk/, DB-ID: AKU_00002). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.